1 Drugs for Malaria Market Overview 1.1 Drugs for Malaria Product Scope 1.2 Drugs for Malaria Segment by Type 1.2.1 Global Drugs for Malaria Sales by Type (2016 & 2021 & 2027) 1.2.2 Aryl Aminoalcohol Compounds 1.2.3 Antifolate Compounds 1.2.4 Artemisinin Compounds 1.3 Drugs for Malaria Segment by Application 1.3.1 Global Drugs for Malaria Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Prevention 1.3.3 Treatment 1.3.4 Others 1.4 Drugs for Malaria Market Estimates and Forecasts (2016-2027) 1.4.1 Global Drugs for Malaria Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Drugs for Malaria Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Drugs for Malaria Price Trends (2016-2027) 2 Drugs for Malaria Estimates and Forecasts by Region 2.1 Global Drugs for Malaria Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Drugs for Malaria Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Drugs for Malaria Sales Market Share by Region (2016-2021) 2.2.2 Global Drugs for Malaria Revenue Market Share by Region (2016-2021) 2.3 Global Drugs for Malaria Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Drugs for Malaria Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Drugs for Malaria Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Drugs for Malaria Estimates and Projections (2016-2027) 2.4.2 Europe Drugs for Malaria Estimates and Projections (2016-2027) 2.4.3 China Drugs for Malaria Estimates and Projections (2016-2027) 2.4.4 Japan Drugs for Malaria Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Drugs for Malaria Estimates and Projections (2016-2027) 2.4.6 India Drugs for Malaria Estimates and Projections (2016-2027) 3 Global Drugs for Malaria Competition Landscape by Players 3.1 Global Top Drugs for Malaria Players by Sales (2016-2021) 3.2 Global Top Drugs for Malaria Players by Revenue (2016-2021) 3.3 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Malaria as of 2020) 3.4 Global Drugs for Malaria Average Price by Company (2016-2021) 3.5 Manufacturers Drugs for Malaria Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Drugs for Malaria Market Size by Type 4.1 Global Drugs for Malaria Historic Market Review by Type (2016-2021) 4.1.1 Global Drugs for Malaria Sales Market Share by Type (2016-2021) 4.1.2 Global Drugs for Malaria Revenue Market Share by Type (2016-2021) 4.1.3 Global Drugs for Malaria Price by Type (2016-2021) 4.2 Global Drugs for Malaria Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Drugs for Malaria Sales Forecast by Type (2022-2027) 4.2.2 Global Drugs for Malaria Revenue Forecast by Type (2022-2027) 4.2.3 Global Drugs for Malaria Price Forecast by Type (2022-2027) 5 Global Drugs for Malaria Market Size by Application 5.1 Global Drugs for Malaria Historic Market Review by Application (2016-2021) 5.1.1 Global Drugs for Malaria Sales Market Share by Application (2016-2021) 5.1.2 Global Drugs for Malaria Revenue Market Share by Application (2016-2021) 5.1.3 Global Drugs for Malaria Price by Application (2016-2021) 5.2 Global Drugs for Malaria Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Drugs for Malaria Sales Forecast by Application (2022-2027) 5.2.2 Global Drugs for Malaria Revenue Forecast by Application (2022-2027) 5.2.3 Global Drugs for Malaria Price Forecast by Application (2022-2027) 6 North America Drugs for Malaria Market Facts & Figures 6.1 North America Drugs for Malaria Sales by Company 6.1.1 North America Drugs for Malaria Sales by Company (2016-2021) 6.1.2 North America Drugs for Malaria Revenue by Company (2016-2021) 6.2 North America Drugs for Malaria Sales Breakdown by Type 6.2.1 North America Drugs for Malaria Sales Breakdown by Type (2016-2021) 6.2.2 North America Drugs for Malaria Sales Breakdown by Type (2022-2027) 6.3 North America Drugs for Malaria Sales Breakdown by Application 6.3.1 North America Drugs for Malaria Sales Breakdown by Application (2016-2021) 6.3.2 North America Drugs for Malaria Sales Breakdown by Application (2022-2027) 7 Europe Drugs for Malaria Market Facts & Figures 7.1 Europe Drugs for Malaria Sales by Company 7.1.1 Europe Drugs for Malaria Sales by Company (2016-2021) 7.1.2 Europe Drugs for Malaria Revenue by Company (2016-2021) 7.2 Europe Drugs for Malaria Sales Breakdown by Type 7.2.1 Europe Drugs for Malaria Sales Breakdown by Type (2016-2021) 7.2.2 Europe Drugs for Malaria Sales Breakdown by Type (2022-2027) 7.3 Europe Drugs for Malaria Sales Breakdown by Application 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027) 8 China Drugs for Malaria Market Facts & Figures 8.1 China Drugs for Malaria Sales by Company 8.1.1 China Drugs for Malaria Sales by Company (2016-2021) 8.1.2 China Drugs for Malaria Revenue by Company (2016-2021) 8.2 China Drugs for Malaria Sales Breakdown by Type 8.2.1 China Drugs for Malaria Sales Breakdown by Type (2016-2021) 8.2.2 China Drugs for Malaria Sales Breakdown by Type (2022-2027) 8.3 China Drugs for Malaria Sales Breakdown by Application 8.3.1 China 243 Sales Breakdown by Application (2016-2021) 8.3.2 China 243 Sales Breakdown by Application (2022-2027) 9 Japan Drugs for Malaria Market Facts & Figures 9.1 Japan Drugs for Malaria Sales by Company 9.1.1 Japan Drugs for Malaria Sales by Company (2016-2021) 9.1.2 Japan Drugs for Malaria Revenue by Company (2016-2021) 9.2 Japan Drugs for Malaria Sales Breakdown by Type 9.2.1 Japan Drugs for Malaria Sales Breakdown by Type (2016-2021) 9.2.2 Japan Drugs for Malaria Sales Breakdown by Type (2022-2027) 9.3 Japan Drugs for Malaria Sales Breakdown by Application 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Drugs for Malaria Market Facts & Figures 10.1 Southeast Asia Drugs for Malaria Sales by Company 10.1.1 Southeast Asia Drugs for Malaria Sales by Company (2016-2021) 10.1.2 Southeast Asia Drugs for Malaria Revenue by Company (2016-2021) 10.2 Southeast Asia Drugs for Malaria Sales Breakdown by Type 10.2.1 Southeast Asia Drugs for Malaria Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Drugs for Malaria Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Drugs for Malaria Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Drugs for Malaria Market Facts & Figures 11.1 India Drugs for Malaria Sales by Company 11.1.1 India Drugs for Malaria Sales by Company (2016-2021) 11.1.2 India Drugs for Malaria Revenue by Company (2016-2021) 11.2 India Drugs for Malaria Sales Breakdown by Type 11.2.1 India Drugs for Malaria Sales Breakdown by Type (2016-2021) 11.2.2 India Drugs for Malaria Sales Breakdown by Type (2022-2027) 11.3 India Drugs for Malaria Sales Breakdown by Application 11.3.1 India Drugs for Malaria Sales Breakdown by Application (2016-2021) 11.3.2 India Drugs for Malaria Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Drugs for Malaria Business 12.1 Cipla 12.1.1 Cipla Corporation Information 12.1.2 Cipla Business Overview 12.1.3 Cipla Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Cipla Drugs for Malaria Products Offered 12.1.5 Cipla Recent Development 12.2 Guilin Pharmaceutical 12.2.1 Guilin Pharmaceutical Corporation Information 12.2.2 Guilin Pharmaceutical Business Overview 12.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Guilin Pharmaceutical Drugs for Malaria Products Offered 12.2.5 Guilin Pharmaceutical Recent Development 12.3 IPCA Laboratories 12.3.1 IPCA Laboratories Corporation Information 12.3.2 IPCA Laboratories Business Overview 12.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021) 12.3.4 IPCA Laboratories Drugs for Malaria Products Offered 12.3.5 IPCA Laboratories Recent Development 12.4 GlaxoSmithKline 12.4.1 GlaxoSmithKline Corporation Information 12.4.2 GlaxoSmithKline Business Overview 12.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021) 12.4.4 GlaxoSmithKline Drugs for Malaria Products Offered 12.4.5 GlaxoSmithKline Recent Development 12.5 Mylan Labs 12.5.1 Mylan Labs Corporation Information 12.5.2 Mylan Labs Business Overview 12.5.3 Mylan Labs Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Mylan Labs Drugs for Malaria Products Offered 12.5.5 Mylan Labs Recent Development 12.6 Roche 12.6.1 Roche Corporation Information 12.6.2 Roche Business Overview 12.6.3 Roche Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Roche Drugs for Malaria Products Offered 12.6.5 Roche Recent Development 12.7 Novartis 12.7.1 Novartis Corporation Information 12.7.2 Novartis Business Overview 12.7.3 Novartis Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Novartis Drugs for Malaria Products Offered 12.7.5 Novartis Recent Development 12.8 Sanofi Aventis 12.8.1 Sanofi Aventis Corporation Information 12.8.2 Sanofi Aventis Business Overview 12.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Sanofi Aventis Drugs for Malaria Products Offered 12.8.5 Sanofi Aventis Recent Development 12.9 Ajanta Pharma 12.9.1 Ajanta Pharma Corporation Information 12.9.2 Ajanta Pharma Business Overview 12.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Ajanta Pharma Drugs for Malaria Products Offered 12.9.5 Ajanta Pharma Recent Development 13 Drugs for Malaria Manufacturing Cost Analysis 13.1 Drugs for Malaria Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Drugs for Malaria 13.4 Drugs for Malaria Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Drugs for Malaria Distributors List 14.3 Drugs for Malaria Customers 15 Market Dynamics 15.1 Drugs for Malaria Market Trends 15.2 Drugs for Malaria Drivers 15.3 Drugs for Malaria Market Challenges 15.4 Drugs for Malaria Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Drugs for Malaria Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Drugs for Malaria Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Drugs for Malaria Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Drugs for Malaria Sales (K Units) by Region (2016-2021) Table 5. Global Drugs for Malaria Sales Market Share by Region (2016-2021) Table 6. Global Drugs for Malaria Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Drugs for Malaria Revenue Share by Region (2016-2021) Table 8. Global Drugs for Malaria Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Drugs for Malaria Sales Market Share Forecast by Region (2022-2027) Table 10. Global Drugs for Malaria Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Drugs for Malaria Revenue Share Forecast by Region (2022-2027) Table 12. Global Drugs for Malaria Sales (K Units) of Key Companies (2016-2021) Table 13. Global Drugs for Malaria Sales Share by Company (2016-2021) Table 14. Global Drugs for Malaria Revenue (US$ Million) by Company (2016-2021) Table 15. Global Drugs for Malaria Revenue Share by Company (2016-2021) Table 16. Global Drugs for Malaria by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Malaria as of 2020) Table 17. Global Drugs for Malaria Average Price (USD/Unit) of Key Company (2016-2021) Table 18. Manufacturers Drugs for Malaria Manufacturing Sites and Area Served Table 19. Manufacturers Drugs for Malaria Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Drugs for Malaria Sales (K Units) by Type (2016-2021) Table 22. Global Drugs for Malaria Sales Share by Type (2016-2021) Table 23. Global Drugs for Malaria Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Drugs for Malaria Price (USD/Unit) by Type (2016-2021) Table 25. Global Drugs for Malaria Sales Share by Type (2022-2027) Table 26. Global Drugs for Malaria Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Drugs for Malaria Revenue Share by Type (2022-2027) Table 28. Global Drugs for Malaria Price (USD/Unit) by Type (2022-2027) Table 29. Global Drugs for Malaria Sales (K Units) by Application (2016-2021) Table 30. Global Drugs for Malaria Sales Share by Application (2016-2021) Table 31. Global Drugs for Malaria Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Drugs for Malaria Price (USD/Unit) by Application (2016-2021) Table 33. Global Drugs for Malaria Sales (K Units) by Application (2022-2027) Table 34. Global Drugs for Malaria Sales Share by Application (2022-2027) Table 35. Global Drugs for Malaria Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Drugs for Malaria Revenue Share by Application (2022-2027) Table 37. Global Drugs for Malaria Price (USD/Unit) by Application (2022-2027) Table 38. North America Drugs for Malaria Sales (K Units) by Company (2016-2021) Table 39. North America Drugs for Malaria Sales Market Share by Company (2016-2021) Table 40. North America Drugs for Malaria Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Drugs for Malaria Revenue Market Share by Company (2016-2021) Table 42. North America Drugs for Malaria Sales by Type (2016-2021) & (K Units) Table 43. North America Drugs for Malaria Sales Market Share by Type (2016-2021) Table 44. North America Drugs for Malaria Sales by Type (2022-2027) & (K Units) Table 45. North America Drugs for Malaria Sales Market Share by Type (2022-2027) Table 46. North America Drugs for Malaria Sales by Application (2016-2021) & (K Units) Table 47. North America Drugs for Malaria Sales Market Share by Application (2016-2021) Table 48. North America Drugs for Malaria Sales by Application (2022-2027) & (K Units) Table 49. North America Drugs for Malaria Sales Market Share by Application (2022-2027) Table 50. Europe Drugs for Malaria Sales (K Units) by Company (2016-2021) Table 51. Europe Drugs for Malaria Sales Market Share by Company (2016-2021) Table 52. Europe Drugs for Malaria Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Drugs for Malaria Revenue Market Share by Company (2016-2021) Table 54. Europe Drugs for Malaria Sales by Type (2016-2021) & (K Units) Table 55. Europe Drugs for Malaria Sales Market Share by Type (2016-2021) Table 56. Europe Drugs for Malaria Sales by Type (2022-2027) & (K Units) Table 57. Europe Drugs for Malaria Sales Market Share by Type (2022-2027) Table 58. Europe Drugs for Malaria Sales by Application (2016-2021) & (K Units) Table 59. Europe Drugs for Malaria Sales Market Share by Application (2016-2021) Table 60. Europe Drugs for Malaria Sales by Application (2022-2027) & (K Units) Table 61. Europe Drugs for Malaria Sales Market Share by Application (2022-2027) Table 62. China Drugs for Malaria Sales (K Units) by Company (2016-2021) Table 63. China Drugs for Malaria Sales Market Share by Company (2016-2021) Table 64. China Drugs for Malaria Revenue by Company (2016-2021) & (US$ Million) Table 65. China Drugs for Malaria Revenue Market Share by Company (2016-2021) Table 66. China Drugs for Malaria Sales by Type (2016-2021) & (K Units) Table 67. China Drugs for Malaria Sales Market Share by Type (2016-2021) Table 68. China Drugs for Malaria Sales by Type (2022-2027) & (K Units) Table 69. China Drugs for Malaria Sales Market Share by Type (2022-2027) Table 70. China Drugs for Malaria Sales by Application (2016-2021) & (K Units) Table 71. China Drugs for Malaria Sales Market Share by Application (2016-2021) Table 72. China Drugs for Malaria Sales by Application (2022-2027) & (K Units) Table 73. China Drugs for Malaria Sales Market Share by Application (2022-2027) Table 74. Japan Drugs for Malaria Sales (K Units) by Company (2016-2021) Table 75. Japan Drugs for Malaria Sales Market Share by Company (2016-2021) Table 76. Japan Drugs for Malaria Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Drugs for Malaria Revenue Market Share by Company (2016-2021) Table 78. Japan Drugs for Malaria Sales by Type (2016-2021) & (K Units) Table 79. Japan Drugs for Malaria Sales Market Share by Type (2016-2021) Table 80. Japan Drugs for Malaria Sales by Type (2022-2027) & (K Units) Table 81. Japan Drugs for Malaria Sales Market Share by Type (2022-2027) Table 82. Japan Drugs for Malaria Sales by Application (2016-2021) & (K Units) Table 83. Japan Drugs for Malaria Sales Market Share by Application (2016-2021) Table 84. Japan Drugs for Malaria Sales by Application (2022-2027) & (K Units) Table 85. Japan Drugs for Malaria Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Drugs for Malaria Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Drugs for Malaria Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Drugs for Malaria Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Drugs for Malaria Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Drugs for Malaria Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Drugs for Malaria Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Drugs for Malaria Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Drugs for Malaria Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Drugs for Malaria Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Drugs for Malaria Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Drugs for Malaria Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Drugs for Malaria Sales Market Share by Application (2022-2027) Table 98. India Drugs for Malaria Sales (K Units) by Company (2016-2021) Table 99. India Drugs for Malaria Sales Market Share by Company (2016-2021) Table 100. India Drugs for Malaria Revenue by Company (2016-2021) & (US$ Million) Table 101. India Drugs for Malaria Revenue Market Share by Company (2016-2021) Table 102. India Drugs for Malaria Sales by Type (2016-2021) & (K Units) Table 103. India Drugs for Malaria Sales Market Share by Type (2016-2021) Table 104. India Drugs for Malaria Sales by Type (2022-2027) & (K Units) Table 105. India Drugs for Malaria Sales Market Share by Type (2022-2027) Table 106. India Drugs for Malaria Sales by Application (2016-2021) & (K Units) Table 107. India Drugs for Malaria Sales Market Share by Application (2016-2021) Table 108. India Drugs for Malaria Sales by Application (2022-2027) & (K Units) Table 109. India Drugs for Malaria Sales Market Share by Application (2022-2027) Table 110. Cipla Corporation Information Table 111. Cipla Description and Business Overview Table 112. Cipla Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 113. Cipla Drugs for Malaria Product Table 114. Cipla Recent Development Table 115. Guilin Pharmaceutical Corporation Information Table 116. Guilin Pharmaceutical Description and Business Overview Table 117. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 118. Guilin Pharmaceutical Drugs for Malaria Product Table 119. Guilin Pharmaceutical Recent Development Table 120. IPCA Laboratories Corporation Information Table 121. IPCA Laboratories Description and Business Overview Table 122. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 123. IPCA Laboratories Drugs for Malaria Product Table 124. IPCA Laboratories Recent Development Table 125. GlaxoSmithKline Corporation Information Table 126. GlaxoSmithKline Description and Business Overview Table 127. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 128. GlaxoSmithKline Drugs for Malaria Product Table 129. GlaxoSmithKline Recent Development Table 130. Mylan Labs Corporation Information Table 131. Mylan Labs Description and Business Overview Table 132. Mylan Labs Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 133. Mylan Labs Drugs for Malaria Product Table 134. Mylan Labs Recent Development Table 135. Roche Corporation Information Table 136. Roche Description and Business Overview Table 137. Roche Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 138. Roche Drugs for Malaria Product Table 139. Roche Recent Development Table 140. Novartis Corporation Information Table 141. Novartis Description and Business Overview Table 142. Novartis Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 143. Novartis Drugs for Malaria Product Table 144. Novartis Recent Development Table 145. Sanofi Aventis Corporation Information Table 146. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Sanofi Aventis Description and Business Overview Table 148. Sanofi Aventis Drugs for Malaria Product Table 149. Sanofi Aventis Recent Development Table 150. Ajanta Pharma Corporation Information Table 151. Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Ajanta Pharma Description and Business Overview Table 153. Ajanta Pharma Drugs for Malaria Product Table 154. Ajanta Pharma Recent Development Table 155. Production Base and Market Concentration Rate of Raw Material Table 156. Key Suppliers of Raw Materials Table 157. Drugs for Malaria Distributors List Table 158. Drugs for Malaria Customers List Table 159. Drugs for Malaria Market Trends Table 160. Drugs for Malaria Market Drivers Table 161. Drugs for Malaria Market Challenges Table 162. Drugs for Malaria Market Restraints Table 163. Research Programs/Design for This Report Table 164. Key Data Information from Secondary Sources Table 165. Key Data Information from Primary Sources List of Figures Figure 1. Drugs for Malaria Product Picture Figure 2. Global Drugs for Malaria Sales Market Share by Type in 2021 & 2027 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Drugs for Malaria Sales Market Share by Application in 2021 & 2027 Figure 6. Prevention Examples Figure 7. Treatment Examples Figure 8. Others Examples Figure 9. Global Drugs for Malaria Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Drugs for Malaria Sales Growth Rate (2016-2027) & (US$ Million) Figure 11. Global Drugs for Malaria Sales (K Units) Growth Rate (2016-2027) Figure 12. Global Drugs for Malaria Price Trends Growth Rate (2016-2027) (USD/Unit) Figure 13. Global Drugs for Malaria Revenue Market Share by Region: 2016 VS 2021 Figure 14. Global Drugs for Malaria Revenue Market Share by Region: 2021 VS 2027 Figure 15. North America Drugs for Malaria Revenue (Million USD) Growth Rate (2016-2027) Figure 16. North America Drugs for Malaria Sales (K Units) Growth Rate (2016-2027) Figure 17. Europe Drugs for Malaria Revenue (Million USD) Growth Rate (2016-2027) Figure 18. Europe Drugs for Malaria Sales (Million USD) Growth Rate (2016-2027) Figure 19. China Drugs for Malaria Revenue (Million USD) Growth Rate (2016-2027) Figure 20. China Drugs for Malaria Sales (Million USD) and Growth Rate (2016-2027) Figure 21. Japan Drugs for Malaria Revenue (Million USD) Growth Rate (2016-2027) Figure 22. Japan Drugs for Malaria Sales (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia Drugs for Malaria Revenue (Million USD) Growth Rate (2016-2027) Figure 24. Southeast Asia Drugs for Malaria Sales (Million USD) Growth Rate (2016-2027) Figure 25. India Drugs for Malaria Revenue (Million USD) Growth Rate (2016-2027) Figure 26. India Drugs for Malaria Sales (Million USD) Growth Rate (2016-2027) Figure 27. Global 5 Largest Drugs for Malaria Players Market Share by Revenue in Drugs for Malaria: 2016 & 2020 Figure 28. Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 29. Global Drugs for Malaria Revenue Share by Type (2016-2021) Figure 30. Global Drugs for Malaria Revenue Growth Rate by Type in 2016 & 2020 Figure 31. Global Drugs for Malaria Revenue Share by Application (2016-2021) Figure 32. Global Drugs for Malaria Revenue Growth Rate by Application in 2016 & 2020 Figure 33. North America Drugs for Malaria Sales Market Share by Type in 2020 Figure 34. North America Drugs for Malaria Sales Market Share by Application in 2020 Figure 35. Europe Drugs for Malaria Sales Market Share by Type in 2020 Figure 36. Europe Drugs for Malaria Sales Market Share by Application in 2020 Figure 37. China Drugs for Malaria Sales Market Share by Type in 2020 Figure 38. China Drugs for Malaria Sales Market Share by Application in 2020 Figure 39. Japan Drugs for Malaria Sales Market Share by Type in 2020 Figure 40. Japan Drugs for Malaria Sales Market Share by Application in 2020 Figure 41. Southeast Asia Drugs for Malaria Sales Market Share by Type in 2020 Figure 42. Southeast Asia Drugs for Malaria Sales Market Share by Application in 2020 Figure 43. India Drugs for Malaria Sales Market Share by Type in 2020 Figure 44. India Drugs for Malaria Sales Market Share by Application in 2020 Figure 45. Key Raw Materials Price Trend Figure 46. Manufacturing Cost Structure of Drugs for Malaria Figure 47. Manufacturing Process Analysis of Drugs for Malaria Figure 48. Drugs for Malaria Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Cipla Guilin Pharmaceutical IPCA Laboratories GlaxoSmithKline Mylan Labs Roche Novartis Sanofi Aventis Ajanta Pharma